• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Marksans Pharma Limited — Updates, 17-11-2025: Press Release

    17-11-2025 | 11:27 am

    Marksans Pharma's UK subsidiary, Relonchem, received Marketing Authorization from UK MHRA for two Mefenamic Acid products. This expands their product portfolio and market access in the UK, poised for revenue growth.

    No comments yet. Be the first to comment!

    All announcements from Marksans Pharma Limited